Evidence map›Paper›PMID 37242547›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Identification of the Hepatic Metabolites of Flumazenil and their Kinetic Application in Neuroimaging.

Wei-Hsi Chen, Chuang-Hsin Chiu, Shiou-Shiow Farn, Kai-Hung Cheng, Yuan-Ruei Huang, Shih-Ying Lee, Yao-Ching Fang, Yu-Hua Lin, Kang-Wei Chang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei-Hsi ChenIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan City 325207, Taiwan.
Chuang-Hsin ChiuDepartment of Nuclear Medicine, Tri-Service General Hospital, Taipei 114202, Taiwan.ORCID 0000-0002-7275-6558
Shiou-Shiow FarnIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan City 325207, Taiwan.
Kai-Hung ChengIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan City 325207, Taiwan.
Yuan-Ruei HuangIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan City 325207, Taiwan.
Shih-Ying LeeIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan City 325207, Taiwan.
Yao-Ching FangTaipei Neuroscience Institute, Taipei Medical University, Taipei 110301, Taiwan.
Yu-Hua LinLaboratory Animal Center, Taipei Medical University, Taipei 110301, Taiwan.
Kang-Wei ChangTaipei Neuroscience Institute, Taipei Medical University, Taipei 110301, Taiwan.ORCID 0000-0002-4476-3603
Institute of Nuclear Energy Research · TWTaipei Medical University · TWTri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies of the neurobiological causes of anxiety disorders have suggested that the γ-aminobutyric acid (GABA) system increases synaptic concentrations and enhances the affinity of GABA

Indexed as

benzodiazepine receptorsflumazenilLC-QqQ MSmetabolismγ-aminobutyric acid receptor antagonist

Identifiers

PMID37242547
PMCPMC10223822
OpenAlexW4377020651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.